We next assessed the expression in cancerous areas of mRNAs encoding several candidate chemokines, including IL-8/CXCL8, Mig/CXCL9, IP-10/CXCL10, I-TAC/CXCL11, CXCL16, MIP-1P-1 L16, MIP-1-α/CCL3, RANTES/CCL5, MCP3/CCL7, HCC-1/CCL14, HCC-2/CCL15, LEC/CCL16, MPIF-1/CCL23, MCP-1/CCL2, MCP-2/CCL8, MCP-4/CCL13, lymphotactin/XCL, and fractalkine/CX3CL. This evidence concerns the gene CCL2 and hepatocellular carcinoma.